Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, André N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL. Ramaswamy V, et al. Among authors: massimino m. Acta Neuropathol. 2016 Jun;131(6):821-31. doi: 10.1007/s00401-016-1569-6. Epub 2016 Apr 4. Acta Neuropathol. 2016. PMID: 27040285 Free PMC article. Review.
Intracranial ependymoma: factors affecting outcome.
Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, Giangaspero F. Massimino M, et al. Future Oncol. 2009 Mar;5(2):207-16. doi: 10.2217/14796694.5.2.207. Future Oncol. 2009. PMID: 19284379 Review.
Childhood medulloblastoma.
Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S. Massimino M, et al. Crit Rev Oncol Hematol. 2011 Jul;79(1):65-83. doi: 10.1016/j.critrevonc.2010.07.010. Epub 2010 Dec 3. Crit Rev Oncol Hematol. 2011. PMID: 21129995 Review.
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R. Lannering B, et al. Among authors: massimino m. J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851561 Clinical Trial.
A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.
Satgé D, Stiller CA, Rutkowski S, von Bueren AO, Lacour B, Sommelet D, Nishi M, Massimino M, Garré ML, Moreno F, Hasle H, Jakab Z, Greenberg M, von der Weid N, Kuehni C, Zurriaga O, Vicente ML, Peris-Bonet R, Benesch M, Vekemans M, Sullivan SG, Rickert C. Satgé D, et al. Among authors: massimino m. J Neurooncol. 2013 Mar;112(1):107-14. doi: 10.1007/s11060-012-1041-y. Epub 2013 Jan 11. J Neurooncol. 2013. PMID: 23307327 Free article.
550 results